Evidence map›Paper›PMID 26195666›Full record

ArticleThe Journal of cell biology2015

IQGAP1 promotes CXCR4 chemokine receptor function and trafficking via EEA-1+ endosomes.

Adebowale O Bamidele, Kimberly N Kremer, Petra Hirsova, Ian C Clift, Gregory J Gores, Daniel D Billadeau, Karen E Hedin

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. The scaffold protein IQGAP1 regulates the epithelial NaThe Journal of biological chemistry · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adebowale O BamideleDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 Department of Immunology, Mayo Clinic, Rochester, MN 55905.
Kimberly N KremerDepartment of Immunology, Mayo Clinic, Rochester, MN 55905.
Petra HirsovaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Ian C CliftDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 Neurobiology of Disease Research Program, Mayo Clinic, Rochester, MN 55905.
Gregory J GoresDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905.
Daniel D BilladeauDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 Division of Oncology Research, Mayo Clinic, Rochester, MN 55905.
Karen E HedinDepartment of Immunology, Mayo Clinic, Rochester, MN 55905 hedin.karen@mayo.edu.
WinnMed · USMayo Clinic in Arizona · US

Funding

MULTIDISCRIPLINARY TRAINING IN DIGESTIVE DISEASEST32DK007198 · NIDDK · MAYO CLINIC ROCHESTER · PI Harmeet Malhi · 1986 to 2026
$8.9M
TRAINING IN TRANSLATIONAL RESEARCH: BENCH TO BEDSIDER25GM055252 · NIGMS · MAYO CLINIC ROCHESTER · PI LUJAN, LUIS, MAHER, LOUIS JAMES · 1996 to 2022
$8.3M
SUPPLEMENT FOR MARC SCIENTIFIC COMMUNICATIONS TECHNOLOGYT34GM008078 · NIGMS · BROOKLYN COLLEGE · PI HAINLINE, LOUISE, RABIN, LAURA A. · 1985 to 2022
$8.2M
CXCR4 CHEMOKINE RECEPTOR REGULATION OF ERK MAP KINASER01GM059763 · NIGMS · MAYO CLINIC ROCHESTER · PI HEDIN, KAREN E. · 1999 to 2015
$4.1M
MECHANISMS OF LIVER CELL INJURYR01DK041876 · NIDDK · MAYO CLINIC ROCHESTER · PI GORES, GREGORY J. · 1992 to 2019
$3.6M
Predoctoral Training Program in Molecular PharmacologyT32GM072474 · NIGMS · MAYO CLINIC ROCHESTER · PI KARNITZ, LARRY M · 2005 to 2020
$2.4M
NIDDK NIH HHS R01 DK041876NIDDK NIH HHS R01DK41876NIDDK NIH HHS T32 DK007198NIGMS NIH HHS R01 GM059763NIGMS NIH HHS R01GM59763NIGMS NIH HHS R25 GM055252NIGMS NIH HHS R25GM55252NIGMS NIH HHS T32 GM072474NIGMS NIH HHS T32GM072474
6 · The paper itself

Abstract

IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a cytoskeleton-interacting scaffold protein. CXCR4 is a chemokine receptor that binds stromal cell-derived factor-1 (SDF-1; also known as CXCL12). Both IQGAP1 and CXCR4 are overexpressed in cancer cell types, yet it was unclear whether these molecules functionally interact. Here, we show that depleting IQGAP1 in Jurkat T leukemic cells reduced CXCR4 expression, disrupted trafficking of endocytosed CXCR4 via EEA-1(+) endosomes, and decreased efficiency of CXCR4 recycling. SDF-1-induced cell migration and activation of extracellular signal-regulated kinases 1 and 2 (ERK) MAPK were strongly inhibited, even when forced overexpression restored CXCR4 levels. Similar results were seen in KMBC and HEK293 cells. Exploring the mechanism, we found that SDF-1 treatment induced IQGAP1 binding to α-tubulin and localization to CXCR4-containing endosomes and that CXCR4-containing EEA-1(+) endosomes were abnormally located distal from the microtubule (MT)-organizing center (MTOC) in IQGAP1-deficient cells. Thus, IQGAP1 critically mediates CXCR4 cell surface expression and signaling, evidently by regulating EEA-1(+) endosome interactions with MTs during CXCR4 trafficking and recycling. IQGAP1 may similarly promote CXCR4 functions in other cancer cell types.

Indexed as

Cell MovementChemokine CXCL12EndocytosisEndosomesHEK293 CellsHumansJurkat CellsMAP Kinase Signaling SystemMicrotubulesProtein Transportras GTPase-Activating ProteinsReceptors, CXCR4Receptors, Opioid, deltaVesicular Transport ProteinsChemokine CXCL12CXCL12 protein, humanCXCR4 protein, humanearly endosome antigen 1IQ motif containing GTPase activating protein 1ras GTPase-Activating ProteinsReceptors, CXCR4Receptors, Opioid, deltaVesicular Transport Proteins

Identifiers

PMID26195666
PMCPMC4508899
OpenAlexW1859281436

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.